115 related articles for article (PubMed ID: 3348429)
1. Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat.
Rabinovitch M; Mullen M; Rosenberg HC; Maruyama K; O'Brodovich H; Olley PM
Am J Physiol; 1988 Mar; 254(3 Pt 2):H500-8. PubMed ID: 3348429
[TBL] [Abstract][Full Text] [Related]
2. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
Morrell NW; Morris KG; Stenmark KR
Am J Physiol; 1995 Oct; 269(4 Pt 2):H1186-94. PubMed ID: 7485548
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of hypoxic pulmonary vasoconstriction by leukotriene blockade].
Burghuber OC; Morganroth ML; Stenmark KR; Morris KG; Reeves JT; Voelkel NF
Wien Klin Wochenschr; 1986 Feb; 98(4):113-7. PubMed ID: 3705592
[TBL] [Abstract][Full Text] [Related]
4. Intralipid effect on normal and hypoxic remodeled rat pulmonary vasculature.
Ilkiw R; Maruyama K; Rabinovitch M
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1499-508. PubMed ID: 2974251
[TBL] [Abstract][Full Text] [Related]
5. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
Ono S; Westcott JY; Voelkel NF
J Appl Physiol (1985); 1992 Sep; 73(3):1084-92. PubMed ID: 1400021
[TBL] [Abstract][Full Text] [Related]
6. Effect of Intralipid on hypoxic and angiotensin-II induced pulmonary vasoconstriction in the isolated rat lung.
Baudouin SV; Messent M; Evans TW
Crit Care Med; 1994 Dec; 22(12):1964-8. PubMed ID: 7988134
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats.
Chen SJ; Chen YF; Meng QC; Durand J; Dicarlo VS; Oparil S
J Appl Physiol (1985); 1995 Dec; 79(6):2122-31. PubMed ID: 8847282
[TBL] [Abstract][Full Text] [Related]
8. [Angiotensin II receptors in a rat model of hypobaric hypoxic pulmonary hypertension].
Mikami O; Nagaoka I; Hasunuma K; Takahashi H
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Feb; 34(2):186-93. PubMed ID: 8622275
[TBL] [Abstract][Full Text] [Related]
9. Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats.
Michael JR; Kennedy TP; Buescher P; Farrukh I; Lodato R; Rock PC; Gottlieb J; Gurtner G; de la Monte SM; Hutchins GM
Am Rev Respir Dis; 1986 Mar; 133(3):375-9. PubMed ID: 2937355
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective and vasomotor effects of HO activity during acute and chronic hypoxia.
Hartsfield CL; McMurtry IF; Ivy DD; Morris KG; Vidmar S; Rodman DM; Fagan KA
Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H2009-15. PubMed ID: 15217799
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation.
Imamura M; Luo B; Limbird J; Vitello A; Oka M; Ivy DD; McMurtry IF; Garat CV; Fallon MB; Carter EP
J Appl Physiol (1985); 2005 Feb; 98(2):739-47. PubMed ID: 15516365
[TBL] [Abstract][Full Text] [Related]
12. Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists.
Stanbrook HS; Morris KG; McMurtry IF
Am Rev Respir Dis; 1984 Jul; 130(1):81-5. PubMed ID: 6742615
[TBL] [Abstract][Full Text] [Related]
13. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
14. [Hypoxic pulmonary vasoconstriction and angiotensin II blockade in calves (author's transl)].
Mattioli L; Zakheim RM; Toyama M; Park MK; Molteni A; Vaseenon T; Nicolosi GL; Zanuttini D
G Ital Cardiol; 1979; 9(12):1382-5. PubMed ID: 549786
[TBL] [Abstract][Full Text] [Related]
15. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.
DiCarlo VS; Chen SJ; Meng QC; Durand J; Yano M; Chen YF; Oparil S
Am J Physiol; 1995 Nov; 269(5 Pt 1):L690-7. PubMed ID: 7491990
[TBL] [Abstract][Full Text] [Related]
16. Perinatal hypoxia increases hypoxic pulmonary vasoconstriction in adult rats recovering from chronic exposure to hypoxia.
Hampl V; Herget J
Am Rev Respir Dis; 1990 Sep; 142(3):619-24. PubMed ID: 2389914
[TBL] [Abstract][Full Text] [Related]
17. The effects of angiotensin II and indomethacin on the pulmonary arterial prostaglandin E levels and pulmonary circulation in dogs.
Ito T; Ogawa K
Jpn Heart J; 1979 Mar; 20(2):195-205. PubMed ID: 449052
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary vascular adaptations to augmented polycythemia during chronic hypoxia.
Petit RD; Warburton RR; Ou LC; Hill NS
J Appl Physiol (1985); 1995 Jul; 79(1):229-35. PubMed ID: 7559224
[TBL] [Abstract][Full Text] [Related]
19. Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism.
Li J; Zhang P; Zhang QY; Zhang SM; Guo HT; Bi H; Wang YM; Sun X; Liu JC; Cheng L; Cui Q; Yu SQ; Kaye AD; Yi DH; Pei JM
Vascul Pharmacol; 2009; 51(2-3):72-7. PubMed ID: 19351568
[TBL] [Abstract][Full Text] [Related]
20. Reduction in hypertension-induced protein synthesis in the rat pulmonary trunk after treatment with teprotide (SQ 20881).
McKenzie JC; Hung KS; Mattioli L; Klein RM
Proc Soc Exp Biol Med; 1984 Nov; 177(2):377-82. PubMed ID: 6207542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
